Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $15.76, but opened at $16.68. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.68, with a volume of 375 shares trading hands.
Wall Street Analyst Weigh In
A number of research analysts have commented on TLX shares. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a research report on Tuesday, November 19th. UBS Group assumed coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They set a "buy" rating and a $21.00 target price on the stock.
Get Our Latest Analysis on TLX
Telix Pharmaceuticals Limited American Depositary Shares Price Performance
About Telix Pharmaceuticals Limited American Depositary Shares
(
Get Free Report)
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
